Cancer

INDICATION: Melanoma; breast cancer

Mouse studies suggest extracellular matrix (ECM)-binding mAbs against PD-L1 and CTLA-4 could help treat melanoma and breast cancer without adverse side effects. The

Read the full 265 word article

User Sign In